Hemorrhagic Cardiac Tamponade-An Unusual Threat in the COVID-19 Recovery Phase

Medicina (Kaunas). 2022 Dec 20;59(1):3. doi: 10.3390/medicina59010003.

Abstract

Cardiac tamponade is a rare presentation in patients with COVID-19, which may be induced by the associated exacerbated inflammatory response. The onset of cardiac tamponade may be concomitant with the acute phase of the disease or may develop subsequently as a new health condition secondary to the disease. We report four cases of cardiac tamponade that occurred late after the acute phase of the disease. One of them may be considered a post-acute complication of the disease, and three of them may be classified as a new health condition induced by COVID-19. Only two cases had a history of severe respiratory distress due to COVID-19. In all four cases, pericardiocentesis was imposed, and surprisingly, in every case, hemorrhagic fluid was evacuated. In this case, series, immune-mediated etiology is supported by histopathological results, where the main identified feature was fibrous pericarditis with inflammatory infiltrate. Only one patient included in this report died, and three of them were discharged after anti-inflammatory treatment was initiated.

Keywords: COVID-19; cardiac tamponade; cardiovascular surgery; coronavirus; critical care; pericardial involvement; pericarditis.

Publication types

  • Case Reports

MeSH terms

  • COVID-19* / complications
  • Cardiac Tamponade* / etiology
  • Cardiac Tamponade* / surgery
  • Humans
  • Pericardiocentesis / adverse effects
  • Pericardiocentesis / methods
  • Pericarditis* / etiology

Grants and funding

This research received no external funding.